SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals
Panacea Biotec
BSE: 531349|NSE: PANACEABIO|ISIN: INE922B01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 01, 12:02
127.50
3 (2.41%)
VOLUME 2,952
LIVE
NSE
Jul 01, 12:02
127.00
2.1 (1.68%)
VOLUME 7,946
Announcements on Panacea Biotec

31st-May-2015 13:16Source: BSE

Panacea Biotec- Financial Results & Auditors Report for March 31, 2015 (Audited)

Panacea Biotec Ltd has informed BSE about the Financial Results & a copy of the Auditors Report for the period ended March 31, 2015.

28th-May-2015 16:51Source: BSE

Panacea Biotec- Outcome of Board Meeting

Panacea Biotec Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2015, had approved the appointment of Mr. Devender Gupta, who is currently working as G.M....

20th-May-2015 18:29Source: NSE

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange that the Board of Directors of the Company has adopted and formulated the Code of Conduct for prevention of Insider Trading and Code of Practices and P...

20th-May-2015 17:51Source: BSE

Panacea Biotec- Code of Conduct of Fair Disclosure

Panacea Biotec Ltd has informed BSE regarding Disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015.

15th-May-2015 17:21Source: BSE

Panacea Biotec- Closure of Trading Window

Panacea Biotec Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 28, 2015, inter alia, to consider and approve the Audited Financial Results for the Fina...

23rd-Apr-2015 18:19Source: NSE

Panacea Biotec Limited

Soshil Kumar Jain has submitted to the Exchange vide letter dated April 06, 2015 a copy of disclosure under Regulation 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

15th-Apr-2015 14:21Source: BSE

Panacea Biotec- Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Soshil Kumar Jain (HUF) has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE

15th-Apr-2015 14:02Source: BSE

Panacea Biotec- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Panacea Biotec Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

15th-Apr-2015 12:15Source: BSE

Panacea Biotec- Shareholding Pattern For March 31, 2015

Panacea Biotec Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015.

30th-Mar-2015 16:48Source: NSE

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange that Mrs. Manjula Upadhyay, has been appointed as Non-Executive Independent Director of the Company w.e.f. March 30, 2015.

1 2 3 4 5 Next >>
Quick Links for Panacea Biotec
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.